Chitinase induces lysis of MCF-7 cells in culture and of human breast cancer xenograft B11-2 in SCID mice

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3167-3172

  Pan, Xing Q ^a   Shih, Chu C ^b   Harday, John ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Breast cancer xenograft; Chitinase; Lysis; MCF 7 cells

Indexed keywords

CHITINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHITINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; MICE, SCID; NECROSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 23344444459     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Dwek MV and Brooks SA: Harnessing changes in cellular glycosylation in new cancer treatment strategies. Curr Cancer Drug Targets 4: 425-442, 2004.
2. Chiu Yi-Jen and Lin Chun-Cheng: Carbohydrate antigen and vaccine. Huaxue 58: 301-308, 2000.
3. Oerntoft TF and Vestergaard EM: Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 20: 362-371, 1999.
4. Lemieux GA and Bertozzi CR: Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens. Chem Biol 8: 265-275, 2001.
5. Barchi JJ: Emerging roles of carbohydrates and glycomimetics in anticancer drug design. Curr Pharm Des 6: 485-501, 2000.
6. Muramatsu T: Carbohydrate signals in metastasis and prognosis of human carcinomas. Glycobiology 3: 294-296, 1993.
7. Fukuda M: Possible roles of tumor-associated carbohydrate antigen. Perspect Cancer Res 56: 2237-2244, 1996.
8. Bhavanandan VP: Cancer associated mucins and mucin-type glycoproteins. Glycobiology 1: 493-501, 1991.
9. Samuel BH and Toung SK: Carbohydrate antigens on cancer-associated mucin like molecules. Semin Cancer Biol 2: 389-400, 1991.
10. Lioyd KO, Burchell J, Kudryashov V, Yin BWT and Taylor-Papadimitriou J: Comparison of O-linked carbohydrate in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. J Biol Chem 271: 33325-33334, 1996.
11. Hakomori SI: Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 45: 2405-2414, 1985.
12. Warren L, Buck CA. and Tuszynski GP: Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behavior. Biochm Biophys Acta 516: 97-123, 1978.
13. Dannis JW: Changes in glycosylation associated with malignant transformation and tumor progression. In: Cell Surface Carbohydrates and Cell Development, Fukuda M (ed.). London, CRC Press, pp. 161-194, 1992.
14. Gorelik E, Galili U and Raz A: On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 20: 245-277, 2001.
15. Taki T: Cancer-associated alterations of glycoconjugates-special reference to glycosphingolipids. Nippon Geka Gakkai Zasshi 97: 123-130, 1996.
16. Saiki I, Murata J, Nakajima M, Tokura S and Azuma I: Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic melanoma cells. Cancer Res 50: 3631-3637, 1990.
17. Ahadeff JA: Malignant cell glycoproteins and glycolipids. Crit Rev Oncol Hematol 9: 37-107, 1989.
18. Piller F, Piller V, Fox RI and Fukuda M: Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem 263: 15146-15150, 1988.
19. Haltiwanger RS: Regulation of signal transduction pathways in development by glycosylation. Curr Opin Struct Biol 12: 593-598, 2002.
20. Parham P: Functions for MHC class I carbohydrates inside and outside the cell. TIBS 21: 427-433, 1996.
21. Haltiwanger RS: Glycoprotein-mediated cell interactions, O-linked. Encyclopedia Biol Chem 2: 277-282, 2004.
22. Brandley BK and Schnaar RL: Cell-surface carbohydrates in cell recognition and response. J Leukocyte Biol 40: 97-111, 1986.
23. Smets LA, Enninga IC and Van RH: Cell communication reduced by changes in cell surface carbohydrates. Exp Cell Res 139: 181-189, 1082.
24. Reisfeld RA and Cheresh DA: Human tumor antigens. Adv Immunol 40: 323-377, 1987.
25. Livingston PO and Ragupathi G: Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plane. Cancer Immunol Immunother 45: 10-19, 1997.
26. Rheinnecker M, Hardt C, Ilag LL, Kufer P, Gruber R, Hoess A. Lupas A, Rottenberger C, Pluckthun A and Pack P: Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. J Immunol 157: 2989-2997, 1996.
27. Lin Chun-Hung: Carbohydrate chemistry and development of new drugs. Huaxue 58: 341-345, 2000.
28. Yarema KJ and Bertozzi CR: Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. Curr Opin Chem Biol 2: 49-61, 1998.
29. Panchal RG: Novel therapeutic strategies to selectively kill cancer. Biochem Pharmacol 55: 247-252, 1998.
30. Kiefel MJ: Glycoscience as the basis for drug discovery in the 21th centry. Chem Australia 69: 11-14, 2002.
31. Ragupathi G and Livingston PO: Conjugate vaccines with natural and synthetic carbohydrates can induce antibodies against a variety of tumor cell surface antigens. Rec Res Develop Cancer 2: 39-53, 2000.
32. Lin J, Lin E and Nemunaitis J: Bacteria in the treatment of cancer. Curr Opin Mol Therap 6: 629-639, 2004.
33. Jeljaszewicz J, Pulverer G and Roszlowsli W (eds.). Bacteria and Cancer; Academic Press Inc. New York, 1982.
34. Claudin-4: A new target for pancreatic cancer treatment using Clostridium perfringens exterotoxin. Gastroenterology 121: 678-684, 2001.
35. Pawelek JM, Sodi S, Chakraborty AK Platt JT, Miller S, Holden DW, Hensel M and Low KB: Salmonella pathogenicity island-2 and anticancer activity in mice. Cancer Gene Ther 9: 813-818, 2002.
36. Dang LH, Bettegowda C, Huso DL, Kinzler KW and Vogelstein: Combination bacteriolytic therapy for the treatment of experimental tumors. PNAS: 15155-15160, 2001.
37. Boot RG, Renkema GH, Strijland A and Zonneveld AJV: Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem 270: 26252-26256, 1995.
38. Escott GM and Adams DJ: Chitinase activity in human serum and leukocytes. Infec Immun 63: 4770-4773, 1995.
39. Chihara G, Maeda Y, Hamuro J, Sasaki T and Fukuoka F: Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (berk.) sing. Nature 222: 687, 1969.
40. Chihara G, Hamuro J, Maeda Y, Arai Y and Fukuoka F: Antitumour polysaccharide derive chemically from natural glucan (pachyman). Nature 225: 943-944, 1970.
41. Hashimoto K, Okawa Y, Suzuki K, Okura Y, Suzuki S and Suzuki M: Antitimor activity of acidic mannan fraction from bakers' yeast. J Pharm Dyn 6: 668-676, 1983.
42. Suzuki K, Mikami T, Okawa Y, Tokoro A, Suzuki S and Suzuki M: Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose. Carbohydrate Res 151: 403-408, 1986.
43. Kobayashi M, Watanabe T, Suzuki S and Suzuki M: Effect of N-acetylchitohexaose against Candida albicans infection of tumor-bearing mice. Microbiol Immunol 34: 413-426, 1990.
44. Roby D, Gadelle A and Toppan A: Chitin oligosaccharides as elicitors of chitinase activity in melon plants. Biochem Biophys Res Commu 143: 885-892, 1987.
45. Pan XQ, Hardy J, Lee R, Shih CC and Wang HQ: Chitinase selectively attack tumor cells and cure the cancer transplanted model mice. Minerva Med 92(Suppl.1): 127-128, 2001.